相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pulmonary Spray Dried Powders of Tobramycin Containing Sodium Stearate to Improve Aerosolization Efficiency
Chiara Parlati et al.
PHARMACEUTICAL RESEARCH (2009)
Preparation of microsized spherical aggregates of ultrafine ciprofloxacin particles for dry powder inhalation (DPI)
Hong Zhao et al.
POWDER TECHNOLOGY (2009)
New Aerosol Delivery Devices for Cystic Fibrosis
Kenneth C. Kesser et al.
RESPIRATORY CARE (2009)
Aerosol Antibiotics in Cystic Fibrosis
David E. Geller
RESPIRATORY CARE (2009)
Microparticles for inhalational delivery of antipseudomonal antibiotics
Michael D. Tsifansky et al.
AAPS JOURNAL (2008)
Development of spray dried liposomal dry powder inhaler of Dapsone
Mahavir Chougule et al.
AAPS PHARMSCITECH (2008)
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
Karen S. McCoy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Pharmacoscintigraphic and pharmacokinetic evaluation of tobramycin DPI formulations in cystic fibrosis patients
Gabrielle Pilcer et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Aerosolized antibiotics for non-cystic fibrosis bronchiectasis
Bruce K. Rubin
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2008)
Formulation of rifampicin-cyclodextrin complexes for lung nebulization
Frederic Tewes et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Cospray dried antibiotics for dry powder lung delivery
Handoko Adi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Formulation, characteristics and aerosolization performance of azithromycin DPI prepared by spray-drying
Min Zhao et al.
POWDER TECHNOLOGY (2008)
A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection
George Z. Retsch-Bogart et al.
PEDIATRIC PULMONOLOGY (2008)
Pulmonary versus systemic delivery of antibiotics:: Comparison of vancomycin dispositions in the isolated rat lung
Maria Jose de Jesus Valle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
NanoCipro encapsulation in monodisperse large porous PLGA microparticles
Matthew M. Arnold et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model
L. Garcia-Contreras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety
David E. Geller et al.
PEDIATRIC PULMONOLOGY (2007)
Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis
Ronald L. Gibson et al.
PEDIATRIC PULMONOLOGY (2006)
Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation
Gabrielle Pilcer et al.
PHARMACEUTICAL RESEARCH (2006)
Inhaled azithromycin therapy
AJ Hickey et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2006)
A randomized trial of inhaled cyclosporine in lung-transplant recipients
AT Iacono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis
A Zahoor et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis
R Pandey et al.
TUBERCULOSIS (2005)
A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis
P Scheinberg et al.
CHEST (2005)
Antiinflammatory therapies for cystic fibrosis: Past, present, and future
WA Prescott et al.
PHARMACOTHERAPY (2005)
The development of a novel high-dose pressurized aerosol dry-powder device (PADD) for the deliverv of pumactant for inhalation therapy
PM Young et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2004)
Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers
MT Newhouse et al.
CHEST (2003)
Fundamentals of pulmonary drug delivery
DA Groneberg et al.
RESPIRATORY MEDICINE (2003)
Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications
NR Labiris et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system
DE Geller et al.
CHEST (2003)
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
ME Hodson et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients
GC Wood et al.
PHARMACOTHERAPY (2002)
Dry powder inhalation of antibiotics in cystic fibrosis therapy:: part 2 Inhalation of a novel colistin dry powder formulation:: a feasibility study in healthy volunteers and patients
PPH Le Brun et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2002)
Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis
DE Geller et al.
CHEST (2002)
Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle
AH de Boer et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2002)
Improved lung delivery from a passive dry powder inhaler using an engineered PulmoSphere® powder
SP Duddu et al.
PHARMACEUTICAL RESEARCH (2002)
Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis
R Sharma et al.
PHARMACEUTICAL RESEARCH (2001)
分享论文
